Meloxicam Generis

Meloxicam, the active ingredient in Meloxicam Generis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve pain and inflammation in musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain episodes.

GNH USA supplies Meloxicam Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam acts on inflammatory pathways to reduce pain and swelling in several rheumatic disorders.

Osteoarthritis: improves joint function and reduces chronic pain. Rheumatoid arthritis: decreases inflammation and joint damage progression. Ankylosing spondylitis: alleviates spinal stiffness and pain. Acute pain: provides rapid relief of moderate to severe pain.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal pain. - Diarrhea or constipation. - Headache or dizziness. - Elevated blood pressure. - Mild skin rash. - Fluid retention or peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, potentially perforation. - Severe cardiovascular events such as myocardial infarction or stroke. - Acute renal failure or worsening of chronic kidney disease. - Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity with marked liver enzyme elevation. - Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly. - Gastrointestinal risk: assess history of ulcers or bleeding and consider gastro‑protective agents. - Renal function: monitor serum creatinine and urine output, especially in the elderly. - Cardiovascular health: evaluate for hypertension or heart disease and use the lowest effective dose. - Concomitant medications: review use of anticoagulants, diuretics, or other NSAIDs. - Hypersensitivity: discontinue if signs of severe allergic reaction appear. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: reduced renal clearance leading to toxicity. - Methotrexate: heightened risk of bone marrow suppression and hepatotoxicity.

Moderate Interactions (Monitor Closely):\n- Antihypertensives (ACE inhibitors, ARBs, beta‑blockers): possible reduction in blood pressure control. - Diuretics (loop or thiazide): may impair renal function and increase electrolyte disturbances. - Selective serotonin reuptake inhibitors (SSRIs): additive risk of gastrointestinal bleeding. - Oral hypoglycemics: potential alteration of blood glucose control.